staphylococcu
aureu
commonli
detect
earli
life
respiratori
tract
children
cf
staphylococcu
aureu
preval
organ
children
cf
unit
state
reach
highest
preval
age
year
infect
patient
age
group
staphylococcu
aureu
gramposit
coccu
typic
grow
aerob
condit
also
grow
facult
anaerob
usual
consid
commens
human
skin
commonli
isol
anterior
nare
skin
creas
key
virul
factor
aureu
includ
leukocytolyt
toxin
leukocidin
associ
necrot
lung
infect
addit
small
coloni
variant
biofilm
format
may
contribut
increas
antimicrobi
resist
acceler
lung
diseas
although
pathogen
methicillinsensit
aureu
mssa
question
coinfect
pathogen
p
aeruginosa
may
associ
worsen
clinic
outcom
includ
sever
lung
diseas
methicillinresist
aureu
mrsa
infect
tend
occur
commonli
young
adult
rather
children
methicillin
resist
due
presenc
alter
penicillin
bind
protein
encod
meca
gene
belong
staphylococc
cassett
chromosom
scc
least
type
scc
mec
element
describ
date
epidemiolog
mrsa
scc
mec
typespecif
hospitalassoci
mrsa
hamrsa
strain
often
scc
mec
type
ii
iii
wherea
communityassoci
mrsa
camrsa
strain
tend
carri
scc
mec
type
iv
v
addit
meca
neg
mrsa
also
known
borderlin
oxacillinresist
aureu
borsa
describ
cf
resist
variou
potenti
mechan
includ
hyper
enzym
product
plasmidmedi
induc
methicillinas
modif
penicillinbind
protein
gene
initi
epidemiolog
studi
children
cf
demonstr
twothird
mrsa
infect
hamrsa
scc
mec
ii
strain
onethird
camrsa
scc
mec
iv
strain
howev
sccmec
iv
strain
increas
recent
year
preval
mrsaposit
cultur
increas
threefold
individu
cf
live
unit
state
chronic
mrsa
infect
particular
signific
associ
sever
neg
clinic
outcom
includ
acceler
declin
lung
function
increas
hospit
earlier
mortal
patient
cf
ren
et
al
note
significantli
lower
lung
function
mrsainfect
individu
cf
compar
predomin
mssaposit
respiratori
tract
cultur
individu
cf
mrsa
posit
higher
rate
hospit
increas
use
oral
inhal
intraven
antibiot
compar
mrsaneg
patient
furthermor
dasenbrook
et
al
report
rate
lung
function
declin
greater
patient
mrsa
compar
mrsaneg
patient
patient
age
year
mrsaposit
patient
forc
expiratori
volum
second
fev
declin
predictedyear
compar
predictedyear
without
mrsa
predictedyear
confid
interv
ci
p
summari
although
mssa
mrsa
common
pathogen
cf
airway
mrsa
particular
associ
detriment
outcom
patient
cf
pseudomona
aeruginosa
import
gramneg
pathogen
patient
cf
nonlactos
ferment
commonli
found
freshwat
grow
optim
temperatur
growth
pseudomona
aeruginosa
sever
virul
factor
associ
infect
host
includ
flagella
make
motil
organ
well
pili
facilit
attach
epitheli
cell
respiratori
tract
pseudomona
aeruginosa
express
three
main
exopolysaccharid
algin
pel
psl
import
establish
mainten
biofilm
structur
grow
mainli
aerob
also
surviv
anaerob
condit
pseudomona
aeruginosa
intrins
resist
antibiot
acquir
antimicrobi
resist
via
either
chromosom
mutat
horizont
gene
transfer
per
cf
foundat
patient
registri
annual
report
percentag
individu
posit
cultur
p
aeruginosa
declin
time
largest
decreas
observ
among
individu
younger
year
percent
posit
cultur
compar
percent
decreas
p
aeruginosa
infect
preval
may
due
earli
antibiot
erad
treatment
incid
infect
individu
cf
unit
state
cultur
posit
p
aeruginosa
pseudomona
aeruginosa
often
initi
acquir
environment
sourc
bacteria
establish
cf
airway
undergo
adapt
chang
decreas
motil
downregul
flagellum
express
addit
downregul
virul
factor
p
aeruginosa
also
overproduc
exopolysaccharid
algin
confer
mucoidi
statu
chronic
infect
often
monoclon
undergo
adapt
diversif
clonal
variant
associ
acceler
lung
function
declin
earlier
mortal
prevent
poor
outcom
initi
newonset
p
aeruginosa
infect
usual
aggress
treat
attempt
erad
organ
airway
howev
erad
failur
remain
problem
patient
popul
chronic
phenotyp
isol
mucoid
statu
risk
factor
erad
failur
bcc
includ
speci
nonfer
gramneg
bacilli
acquir
environ
transmit
person
person
burkholderia
speci
grow
aerob
condit
organ
frequent
found
environ
especi
soil
pot
plant
consid
highli
virul
organ
factor
pili
facilit
epitheli
cell
attach
extracellular
proteas
result
tissu
damag
quorum
sens
gene
facilit
biofilm
format
type
iii
secret
system
promot
cellular
invas
previous
mention
bcc
speci
intrins
resist
sever
differ
antimicrobi
class
includ
aminoglycosid
due
efflux
pump
via
induc
chromosom
encod
epidemiolog
bcc
infect
cf
extens
examin
given
potenti
transmiss
patient
percent
individu
cf
cf
foundat
patient
registri
annual
report
cultur
posit
bcc
earli
epidemiolog
studi
burkholderia
cenocepacia
initi
describ
common
bcc
organ
individu
cf
speci
link
sever
epidem
strain
worldwid
particular
b
cenocepacia
strain
caus
one
largest
epidem
cf
individu
canada
unit
kingdom
sinc
associ
poor
clinic
outcom
epidemiolog
bcc
infect
cf
chang
last
sever
decad
howev
burkholderia
multivoran
becom
common
b
cenocepacia
thought
due
implement
reinforc
infect
control
prevent
measur
lower
b
cenocepacia
acquisit
rate
wherea
b
multivoran
may
often
acquir
environ
burkholderia
gladioli
close
relat
speci
third
common
burkholderia
speci
isol
cf
part
bcc
burkholderia
cenocepacia
particular
import
cf
associ
poor
clinic
outcom
includ
acceler
lung
function
declin
well
increas
mortal
lung
transplant
addit
b
cenocepacia
well
speci
b
multivoran
link
cepacia
syndrom
clinic
entiti
character
necrot
pneumonia
sepsi
neartot
fatal
rate
therefor
infect
bcc
speci
remain
import
concern
cf
popul
due
signific
associ
morbid
mortal
stenotrophomona
speci
gramneg
rod
oblig
aerob
nonfer
oxidaseneg
organ
found
water
sourc
environ
although
four
speci
stenotrophomona
exist
maltophilia
common
one
identifi
human
host
stenotrophomona
maltophilia
virul
factor
includ
extracellular
enzym
alkalin
serin
proteas
outer
membran
lipopolysaccharid
abil
form
biofilm
antimicrobi
resist
may
occur
due
presenc
multidrug
efflux
pump
aminoglycosidemodifi
enzym
reduc
outer
membran
permeabl
preval
maltophilia
shown
vari
high
cf
popul
previous
identifi
risk
factor
acquisit
includ
antibiot
use
particular
follow
use
antipseudomon
agent
initi
infect
thought
due
acquisit
environment
sourc
rather
persontoperson
transmiss
previou
studi
describ
individu
cf
infect
maltophilia
infect
tend
older
lower
baselin
lung
function
compar
patient
without
maltophilia
howev
studi
maltophilia
individu
rapidli
declin
percent
predict
fev
ppfev
decreas
surviv
howev
chronic
maltophilia
infect
defin
two
posit
cultur
year
prior
describ
signific
risk
factor
pulmonari
exacerb
treat
intraven
antibiot
howev
associ
higher
risk
fail
recov
baselin
lung
function
follow
exacerb
event
addit
registrybas
studi
shown
patient
chronic
maltophilia
three
time
higher
risk
death
lung
transplant
compar
without
maltophilia
infect
achromobact
speci
gramneg
catalaseposit
oxidaseposit
nonsporul
rod
speci
known
within
achromobact
genu
date
achromobact
speci
tend
grow
aerob
nonfer
condit
optim
temperatur
environment
organ
commonli
found
soil
water
achromobact
speci
motil
due
presenc
flagella
exhibit
bind
factor
mucin
collagen
fibronectin
therebi
facilit
initi
attach
invas
respiratori
tract
biofilm
format
well
intrins
resist
sever
class
antimicrobi
express
efflux
pump
aminoglycosidemodifi
enzym
also
express
group
pathogen
achromobact
xylosoxidan
common
achromobact
speci
identifi
individu
cf
account
achromobact
respiratori
tract
infect
preval
achromobact
infect
vari
greatli
report
acquisit
thought
occur
mostli
environ
although
patienttopati
transmiss
previous
describ
publish
data
regard
risk
factor
initi
infect
clinic
impact
achromobact
infect
limit
includ
studi
small
sampl
size
risk
factor
chronic
infect
includ
older
age
chronic
p
aeruginosa
infect
note
patient
chronic
achromobact
infect
lower
lung
function
pulmonari
exacerb
age
gender
p
aeruginosa
match
control
one
main
observ
studi
assess
clinic
outcom
patient
achromobact
infect
larg
epidemiolog
studi
use
toronto
cf
databas
chronic
achromobact
infect
defin
two
posit
cultur
previou
month
associ
twofold
increas
risk
death
lung
transplant
compar
patient
histori
achromobact
infect
current
consensu
data
exist
optim
treatment
strategi
initi
acquisit
treatment
pulmonari
exacerb
chronic
suppress
achromobact
infect
anaerob
group
gramposit
gramneg
organ
requir
reduc
oxygen
surviv
commonli
found
variou
mucos
surfac
human
bodi
includ
upper
airway
gastrointestin
tract
femal
genit
tract
associ
invas
suppur
infect
brain
sinus
lung
liver
blood
vessel
capsular
polysaccharid
hemolysin
proteas
lipopolysaccharid
virul
factor
associ
pathogen
anaerob
due
technic
difficulti
isol
identifi
anaerob
culturedepend
method
preval
anaerob
infect
patient
cf
well
known
recent
cultureindepend
method
help
identifi
anaerob
bacteria
found
abund
quantiti
sputum
bronchoalveolar
lavag
fluid
individu
cf
densiti
estim
coloni
form
unit
cfu
ml
sputum
main
anaerob
bacteria
found
cf
airway
includ
prevotella
veillonella
fusobacterium
propionibacterium
actinomyc
howev
role
anaerob
cf
lung
diseas
remain
controversi
recent
year
studi
describ
associ
detect
anaerob
diminish
clinic
respons
system
antimicrobi
lung
function
declin
one
major
limit
studi
anaerob
cf
lung
diseas
risk
contamin
lower
airway
sampl
oropharyng
secret
collect
although
recent
studi
tri
address
concern
anaerob
may
interact
organ
present
cf
airway
increas
virul
p
aeruginosa
transfer
extendedspectrum
p
aeruginosa
exampl
contrast
potenti
benefici
role
anaerob
also
describ
studi
use
culturedepend
cultureindepend
method
patient
expos
antimicrobi
therapi
may
experi
decreas
rel
abund
anaerob
subsequ
increas
inflamm
decreas
lung
function
therefor
reduc
microbi
commun
divers
regard
anaerob
may
play
role
cf
lung
diseas
progress
role
virus
cf
airway
diseas
increasingli
recogn
recent
year
due
ongo
advanc
molecular
detect
use
method
polymeras
chain
reaction
molecular
assay
allow
rapid
highli
sensit
rel
costeffect
identif
virus
respiratori
tract
viral
cultur
serolog
use
main
method
detect
past
techniqu
limit
due
high
cost
labor
intens
lack
sensit
overal
preval
viral
infect
pulmonari
exacerb
individu
cf
estim
howev
viral
infect
may
underreport
due
infrequ
use
viral
swab
limit
number
respiratori
virus
detect
given
assay
commonli
identifi
virus
cf
patient
respiratori
syncyti
viru
rsv
human
rhinoviru
influenza
type
b
parainfluenza
viru
although
mani
virus
includ
human
metapneumoviru
picornaviru
coronaviru
coxsackieechoviru
also
describ
viral
infect
detect
frequent
children
adult
cf
addit
children
cf
like
experi
signific
morbid
associ
viral
infect
compar
children
without
cf
increas
sever
viral
infect
individu
cf
compar
noncf
popul
link
reduc
innat
antivir
respons
wherebi
cf
individu
may
mount
suffici
interferon
respons
adequ
express
certain
interferonstimul
gene
compar
noncf
control
viral
infect
increas
risk
pulmonari
exacerb
children
adult
cf
well
increas
inflammatori
marker
lead
longer
durat
intraven
antibiot
therapi
greater
drop
lung
function
rsv
particular
import
cf
frequent
encount
children
adult
cf
result
sever
symptom
symptom
may
includ
rhinosinus
cough
fever
acut
otiti
media
rsv
infect
also
progress
lower
airway
diseas
bronchiol
pneumonia
exacerb
chronic
airway
diseas
recent
studi
highlight
children
cf
increas
rsvrelat
admiss
hospit
compar
healthi
children
infant
cf
diseas
rsv
associ
signific
respiratori
morbid
increas
rate
pulmonari
exacerb
longer
stay
hospit
well
prolong
lower
airway
diseas
year
follow
initi
respiratori
infect
describ
patient
similarli
influenza
viru
infect
also
associ
signific
morbid
children
cf
studi
describ
increas
risk
admiss
hospit
pulmonari
exacerb
associ
influenza
infect
compar
without
potenti
mechan
worsen
clinic
outcom
individu
cf
contract
respiratori
viral
infect
may
due
interact
virus
bacteri
speci
airway
subsequ
chang
microbi
commun
composit
viral
infect
link
new
acquisit
p
aeruginosa
previous
cultureneg
patient
convers
intermitt
chronic
p
aeruginosa
infect
patient
cf
rsv
infect
also
link
increas
p
aeruginosa
biofilm
format
dysregul
iron
homeostasi
cf
airway
epithelium
similarli
studi
previous
shown
identif
rhinoviru
aureu
among
frequent
viralbacteri
coinfect
children
summari
viral
infect
import
compon
cf
airway
microbi
commun
contribut
cf
lung
diseas
sever
differ
yeast
filament
fungi
recov
respiratori
tract
secret
cf
patient
direct
microscop
examin
specimen
use
fungal
stain
reveal
yeast
cell
pseudohypha
hypha
sever
media
use
improv
recoveri
fungi
clinic
specimen
fungal
growth
take
long
week
depend
speci
identif
fungal
isol
done
use
microscop
examin
biochem
test
dna
sequenc
analysi
matrix
assist
laser
desorpt
ionizationtim
flight
malditof
mass
spectrometri
common
filament
fungi
recov
cf
airway
aspergillu
speci
preval
rate
often
recoveri
aspergillu
speci
cf
sputum
repres
asymptomat
colon
repres
allerg
bronchopulmonari
aspergillosi
abpa
abpa
character
asthmalik
symptom
posit
aspergillu
skin
test
elev
serum
ige
episod
abpa
lead
declin
pulmonari
function
typic
treat
system
steroid
occasion
aspergillu
caus
bronchiti
associ
increas
pulmonari
inflamm
studi
children
cf
chronic
aspergillu
fumigatu
infect
found
independ
risk
factor
pulmonari
exacerb
treat
intraven
antibiot
although
patient
persist
fumigatu
infect
lower
ppfev
cours
studi
compar
uninfect
signific
interact
fumigatu
p
aeruginosa
lung
function
intervent
studi
itraconazol
treatment
cf
patient
chronic
infect
aspergillu
speci
demonstr
benefit
term
lung
function
occurr
pulmonari
exacerb
compar
placebotr
patient
invas
pulmonari
aspergillosi
occur
rare
immunocompet
individu
cf
pretranspl
scedosporium
speci
saprophyt
filament
fungi
much
less
commonli
found
cf
patient
also
caus
seriou
invas
diseas
immunocompromis
condit
scedosporiosi
infect
involv
lung
bone
eye
blood
vessel
central
nervou
system
exophiala
wangiella
dermatitidi
also
recov
cf
respiratori
specimen
grow
black
yeast
filament
fungu
room
temperatur
anecdot
report
describ
clinic
declin
cf
patient
harbor
e
dermatitidi
sputum
final
candida
speci
frequent
isol
yeast
cf
airway
preval
rang
high
surpris
given
normal
colon
oropharynx
although
studi
suggest
chronic
infect
candida
spp
associ
wors
clinic
outcom
investig
control
potenti
contamin
expector
sputum
sampl
candida
speci
present
oral
caviti
advent
cultureindepend
molecular
method
microbi
detect
understand
microbi
divers
interact
microbi
commun
cf
airway
significantli
expand
newer
techniqu
allow
identif
microorgan
also
estim
rel
abund
microbi
commun
cf
airway
method
ribosom
ribonucl
acid
rrna
gene
sequenc
respiratori
tract
specimen
character
polymicrobi
natur
lower
airway
infect
cf
includ
coexist
classic
cf
pathogen
aerob
anaerob
bacteria
lower
airway
previous
consid
oropharyng
contamin
recent
studi
children
adult
cf
rrna
sequenc
use
investig
lower
airway
microbiota
despit
signific
interindividu
variabl
commun
structur
composit
core
microbiota
includ
streptococcu
prevotella
rothia
veillonella
actinomyc
howev
classic
cf
pathogen
pseudomona
burkholderia
stenotrophomona
achromobact
found
present
tend
domin
microbi
commun
within
individu
zemanick
et
al
also
corrobor
main
find
classic
cf
pathogen
found
commonli
adult
coburn
et
al
zhao
et
al
describ
decreas
microbi
divers
lung
function
age
increas
lung
diseas
progress
overal
find
suggest
microbiom
cf
airway
chang
across
age
diseas
stage
addit
recent
studi
base
rrna
sequenc
highlight
potenti
signific
anaerob
wherebi
rel
abund
anaerob
taxa
respiratori
tract
specimen
individu
cf
domin
pulmonari
exacerb
summari
mani
studi
cf
microbiom
recent
document
divers
much
complex
describ
convent
cultur
alon
chang
rel
abund
structur
microbi
commun
respons
age
diseas
progress
acut
clinic
event
studi
need
understand
chang
impact
clinic
outcom
affect
therapeut
intervent
infect
lower
respiratori
tract
remain
signific
contributor
cf
morbid
mortal
even
era
treatment
correct
andor
potenti
cftr
channel
function
pathogen
mrsa
p
aeruginosa
speci
bcc
continu
signific
clinic
impact
lung
function
mortal
rate
individu
cf
advanc
molecular
technolog
help
understand
microbi
commun
interact
cf
airway
due
ongo
impact
pulmonari
infect
cf
patient
surviv
novel
erad
strategi
effect
chronic
suppress
treatment
need
